Log In
Print this Print this

biosimilar ibalizumab (FB121)

  Manage Alerts
Collapse Summary General Information
Company Fountain Biopharma Inc.
DescriptionBiosimilar of ibalizumab, an antibody against CD4
Molecular Target CD4
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today